Table III.
Association between clinical characteristics of patients with oral squamous cell carcinoma and ERCC1 expression.
ERCC1 expression | |||
---|---|---|---|
Characteristics | Low, n (%) | High, n (%) | P-value |
Age, years | |||
<50 | 19 (47.5) | 28 (48.3) | 0.940 |
≥50 | 21 (52.5) | 30 (51.7) | |
Sex | |||
Male | 36 (90.0) | 56 (96.6) | 0.220a |
Female | 4 (10.0) | 2 (3.4) | |
Smoking | |||
No | 4 (10.0) | 7 (12.1) | >0.999a |
Yes | 36 (90.0) | 51 (87.9) | |
Betel quid chewing | |||
No | 11 (27.5) | 19 (32.8) | 0.580 |
Yes | 29 (72.5) | 39 (67.2) | |
Alcohol consumption | |||
No | 14 (35.0) | 21 (36.2) | 0.900 |
Yes | 26 (65.0) | 37 (63.8) | |
Tumor location | |||
Buccal mucosa | 32 (80.0) | 44 (75.9) | 0.630 |
Tongue | 8 (20.0) | 14 (24.1) | |
Grade | |||
Grade I | 35 (87.5) | 51 (87.9) | >0.999 |
Grade II+III | 5 (12.5) | 7 (12.1) | |
Tumor size | |||
T1+T2 | 22 (55.0) | 30 (51.7) | 0.750 |
T3+T4 | 18 (45.0) | 28 (48.3) | |
Lymph node metastases | |||
N0 | 22 (55.0) | 28 (48.3) | 0.510 |
N1+N2 | 18 (45.0) | 30 (51.7 | |
Tumor stage | |||
I+II | 15 (37.5) | 20 (34.5) | 0.760 |
III+IV | 25 (62.5) | 38 (65.5) | |
Radiotherapy | |||
No | 23 (57.5) | 30 (51.7) | 0.680 |
Yes | 17 (42.5) | 28 (48.3) | |
Chemotherapy | |||
No | 17 (42.5) | 19 (32.8) | 0.330 |
Yes | 23 (57.5) | 39 (67.2) | |
Recurrence | |||
No | 18 (45.0) | 11 (19.0) | 0.006 |
Yes | 22 (55.0) | 47 (81.0) |
Analyzed using Fisher's exact test. ERCC1, excision repair cross-complementing group 1.